TITLE

Hepatitis C virus genotype 3a infection and hepatocellular carcinoma: Pakistan experience

AUTHOR(S)
Idrees, Muhammad; Rafique, Shazia; Rehman, Irshad-ur; Akbar, Haji; Yousaf, Muhammad Zubair; Butt, Sadia; Awan, Zunaira; Manzoor, Sobia; Akram, Madiha; Aftab, Mahwish; Khubaib, Bushra; Riazuddin, Sheikh; Sato, Chifumi; Chan, Henry L. Y.
PUB. DATE
October 2009
SOURCE
World Journal of Gastroenterology;10/28/2009, Vol. 15 Issue 40, p5080
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
AIM: To assess the association between chronic hepatitis C virus (HCV) infection and hepatocellular carcinoma (HCC) in Pakistan, and the genotype distribution among these HCC patients. METHODS: One hundred and sixty-one subjects with HCC were included in this study. Liver biopsy was performed on 145 of the patients; sixteen were excluded because they failed to fulfill the inclusion criteria. Qualitative polymerase chain reaction (PCR) was performed for hepatitis B virus and HCV. Samples positive for HCV RNA were genotyped using genotype-specific PCR and confirmed by HCV 5' noncoding region sequencing analysis. RESULTS: Chronic HCV infection was identified a major risk factor (63.44% of tested HCC patients) for the development of HCC. The time from HCV infection to appearance of cancer was 10-50 years. In the HCC patient population, broader distributions of genotypes were present with genotype 3a as the predominant genotype. Using the type-specific genotyping method, we found HCV genotype 3a in 40.96%, 3b in 15.66%, 1a in 9.63%, and 1b in 2.40% of HCC tissue samples. About 28% of cases were found with mixed genotypes. Two cases were unable to be genotyped because of low viral load. Sixty-six percent of treated patients with cirrhosis had an end of treatment response, but unfortunately they relapsed quickly when the treatment was discontinued, and HCC developed during a median 3.8 years. CONCLUSION: There was a strong association between chronic HCV infection and HCC in Pakistan, and between HCV genotype 3a and HCC.
ACCESSION #
44922492

 

Related Articles

  • Regular surveillance by imaging for early detection and better prognosis of hepatocellular carcinoma in patients infected with hepatitis C virus. Noda, Ikue; Kitamoto, Mikiya; Nakahara, Hideki; Hayashi, Ryohei; Okimoto, Tomoaki; Monzen, Yoshio; Yamada, Hiroyasu; Imagawa, Masaru; Hiraga, Nobuhiko; Tanaka, Junko; Chayama, Kazuaki // Journal of Gastroenterology;Jan2010, Vol. 45 Issue 1, p105 

    This study evaluated the usefulness of regular check-ups by ultrasonography and contrast-enhanced imaging for early detection of hepatocellular carcinoma (HCC) in a retrospective analysis. From April 2001 to March 2007, 240 consecutive patients with HCC who were infected with hepatitis C virus...

  • HCV protein causes cancer.  // AIDS Patient Care & STDs;Dec98, Vol. 12 Issue 12, p943 

    Discusses findings of Japanese researchers that the hepatitis C virus (HVC) core protein induces hepatocellular carcinoma. Development of hepatic steatosis in laboratory mice as histologic feature of chronic hepatitis C; Characteristics of mice carrying HCV envelope genes.

  • Incomplete response of interferon treatment has an important role for the prevention of hepatocellular carcinoma. Hayashi, Norio // Journal of Gastroenterology;1999, Vol. 34 Issue 5, p655 

    Editorial. Focuses on the incidence of hepatocellular carcinoma (HCC) in Japan. Incidence rate of HCC in cirrhotic patients with antibodies to hepatitis C virus (HCV); Treatment of HCV.

  • Iron, hepatitis C virus, and hepatocellular carcinoma: iron reduction preaches the gospel for chronic hepatitis C. Fujita, Naoki; Takei, Yoshiyuki // Journal of Gastroenterology;Nov2007, Vol. 42 Issue 11, p923 

    The article discusses various reports publishes within the issue, including one on chronic hepatitis C virus and another on iron reduction.

  • Hepatocellular carcinoma: advances in proteomics. Chattopadhyay, Dipankar; Reeves, Helen L. // Hot Topics in Viral Hepatitis;2011, Vol. 7 Issue 21, p23 

    The incidence of hepatocellular carcinoma (HCC) is rising dramatically in Europe, driven by the increasing prevalence of cirrhosis associated with hepatitis C virus (HCV) infection and both alcoholic and nonalcoholic fatty liver diseases (ALD and NAFLD, respectively). At the 2011 "Women in...

  • Distribution of Hepatitis C virus genotypes in city of Mashhad, North-east of Iran. Rastin, M.; Mahmoudi, M.; Rezaee, S. A.; Assarehzadegan, M. A.; Tabasi, N.; Zamani, S.; Nosratabadi, R.; Haghmorad, D.; Sheikh, A.; Khazaee, M.; Panah, H. R. // Indian Journal of Medical Microbiology;Jan2014, Vol. 32 Issue 1, p53 

    Purpose: Six major hepatitis C virus genotypes have been characterised, which vary in their geographical distribution. The prevalence of hepatitis C virus (HCV) in an area is not constant, and depends on the changes in route of infection, which may change over time. In this study, the...

  • Interferon Therapy after Tumor Ablation Improves Prognosis in Patients with Hepatocellular Carcinoma Associated with Hepatitis C Virus. Shiratori, Yasushi; Shiina, Shuichiro; Teratani, Takuma; Imamura, Masatoshi; Obi, Shun'taro; Sato, Shin'pei; Koike, Yukihiro; Yoshida, Haruhiko; Omata, Masao // Annals of Internal Medicine;2/18/2003, Vol. 138 Issue 4, p299 

    Studies the efficacy of interferon therapy in patients with hepatocellular carcinoma associated with hepatitis C virus. Criteria for interferon response; Factors associated with sustained response; Adverse events and tolerance; Development of foci of hepatocellular carcinoma; Survival rate of...

  • Abnormalities identified in the liver after HCV eradication. Pockros, Paul J. // Infectious Disease News;Dec2011, Vol. 24 Issue 12, p19 

    The article discusses research from Japan which revealed histological abnormalities in noncancerous liver tissues of patients with hepatocellular cancer following hepatitis C (HCV) eradication.

  • Development of hepatocellular carcinoma after longterm sustained complete response to interferon therapy: what is the mechanism? Tanaka, Naoki; Kiyosawa, Kendo // Journal of Gastroenterology;2003, Vol. 38 Issue 4, p417 

    Editorial. Points out that the development of hepatocellular carcinoma (HCC) after a sustained complete response to interferon presents an interesting and important problem. Development of HCC after a sustained complete response following completion of interferon therapy; Role of the hepatitis...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics